Castle Rock Wealth Management’s Juno Therapeutics, Inc. JUNO Stock Holding History

Castle Rock Wealth Management’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-11,278	Closed	-$516K	–	119
2017 Q4	$516K	Buy	+11,278	New	+$563K	1%	35

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Castle Rock Wealth Management's JUNO Position: Q1 2018 in Review

Castle Rock Wealth Management sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 11,278 shares — an estimated $516K sold.

Castle Rock Wealth Management first reported a position in JUNO in Q4 2017 and held it in 1 quarter. The position peaked at $516K in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Castle Rock Wealth Management reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Castle Rock Wealth Management sold 11,278 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $516K.
Castle Rock Wealth Management first reported a position in Juno Therapeutics, Inc. in Q4 2017 and held it in 1 quarter.
Castle Rock Wealth Management's Juno Therapeutics, Inc. position peaked at $516K in Q4 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Castle Rock Wealth Management's 13F filing for Q1 2018, filed 14 May 2018.